|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alpha 1-Antitrypsin Deficiency | |||||
| 2 | More general conditions related to this trial | ||||
| Connective Tissue Diseases | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Alpha 1-Antitrypsin | |||||
| 4 | More general drug interventions related to this trial | ||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Protease Inhibitors | |||||
| Serine Proteinase Inhibitors | |||||
| Trypsin Inhibitors | |||||
| 5 | Sponsors listed in this trial | ||||
| Baxter Healthcare Corporation | |||||